Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for relapse prevention in alcohol dependence (post-acute treatment)
2009-015537-67Phase 2Terminated
- Sponsor
- University Medical Center Mainz
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol dependence comparing Varenicline (Champix) with Placebo (2 arms). Primary endpoint: Percent of days abstinent from any alcohol during 12-week treatment. Started Oct 2009; status: terminated.
02
Drugs
varenicline
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on 2009-015537-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015537-67.